Myriad Genetics, Inc. (MYGN) Raised to "Hold" at BidAskClub
Other analysts also recently issued reports about the stock. TheStreet upgraded shares of Myriad Genetics from a "d+" rating to a "c" rating in a research report on Wednesday, March 1st.
from Biotech News
0 Comments